Background Angiotensin-converting enzyme (ACE) inhibitors have been reported to be
effective in placebo-controlled trials in various subsets of patients with acute myocardial …

The development of angiotensin-converting enzyme inhibitors (ACE inhibitors) has been
one of the most remarkable stories in the treatment of cardiovascular diseases. Angiotensin …

Ischemic heart disease is the most common cause of congestive heart failure, which often
begins after acute myocardial infarction. To better delineate the clinical characteristics and …

There has been considerable controversy concerning the usefulness of digitalis in patients
with congestive heart failure, and digitalis has never been shown in appropriate studies to …

Written by recognized leaders in the field, Congestive Heart Failure, Third Edition is a
comprehensive, state-of-the-art reference on all basic and clinical aspects of heart failure …

The pharmacological inhibition of the renin-angiotensin-aldosterone system as a therapeutic
strategy is one of the most significant advances in the treatment and prevention of …

Left ventricular remodeling is a dynamic process that occurs in reaction to an insult to the
myocardium. The response to either loss of cells, as may occur following myocardial …

Perioperative myocardial infarction (PMI) is a major cause of morbidity and mortality in
patients undergoing noncardiac surgery. The incidence of PMI varies depending on the …

Based on preclinical and clinical findings, zofenopril appears to be an angiotensin-
converting enzyme (ACE) inhibitor with high potency, significant tissue selectivity and a long …

Aim To determine whether measurement of serum troponin T concentration after first acute
myocardial infarction can be used to identify patients with a left ventricular ejection fraction …